SLN

Silence Therapeutics
SLN

Overview Fund Activity

27 hedge funds and large institutions have $276M invested in Silence Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 4 closing their positions.

Holders
27
Holders Change
-2
Holders Change %
-6.9%
% of All Funds
0.44%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
2
Increased
8
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MCM
1
M28 Capital Management
Connecticut
$2.22M
2
CF
2
Cantor Fitzgerald
New York
$4.6M
3
Morgan Stanley
3
Morgan Stanley
New York
$3.22M
4
SSA
4
Schonfeld Strategic Advisors
New York
$450K
5
ACM
5
Aquilo Capital Management
California
$19.6M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$5.65M
2
UOC
2
UBS O'Connor
Illinois
$0
3
GPP
3
Great Point Partners
Connecticut
$0
4
LOAMU
4
Lombard Odier Asset Management (USA)
New York
$50.6M
5
Citadel Advisors
5
Citadel Advisors
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Deutsche Bank
26
Deutsche Bank
Germany
$60.3K – – –
SPIA
27
Steward Partners Investment Advisory
New York
$1.53K – – –
UOC
28
UBS O'Connor
Illinois
– -$786K -79,636 Closed
GPP
29
Great Point Partners
Connecticut
– -$692K -68,915 Closed
Citadel Advisors
30
Citadel Advisors
Florida
– -$226K -22,851 Closed
CSS
31
Cubist Systematic Strategies
Connecticut
– -$5K -500 Closed
1
2